La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Ncbi)

Index « Auteurs » - entrée « D B Calne »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
D A Westcott < D B Calne < D B Cook  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 76.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000007 (1999) A. Samii [Canada] ; I M Turnbull ; A. Kishore ; M. Schulzer ; E. Mak ; S. Yardley ; D B CalneReassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.
000026 (1999) D B Calne [Canada]Differentiation of dopamine agonists and their role in the treatment of Parkinson's disease.
000028 (????) P K Pal [Canada] ; A. Samii ; D B CalneManganese neurotoxicity: a review of clinical features, imaging and pathology.
000038 (1999) C R Honey [Canada] ; A J Stoessl ; J K Tsui ; M. Schulzer ; D B CalneUnilateral pallidotomy for reduction of parkinsonian pain.
000063 (????) J K Tsui ; D B Calne ; Y. Wang ; M. Schulzer ; S A MarionOccupational risk factors in Parkinson's disease.
000067 (1999) A. Samii [Canada] ; K. Markopoulou ; Z K Wszolek ; V. Sossi ; T. Dobko ; E. Mak ; D B Calne ; A J StoesslPET studies of parkinsonism associated with mutation in the alpha-synuclein gene.
000069 (2000) P K Pal [Canada] ; D B Calne ; S. Calne ; J K TsuiBotulinum toxin A as treatment for drooling saliva in PD.
000093 (2000) C S Lee [Canada] ; A. Samii ; V. Sossi ; T J Ruth ; M. Schulzer ; J E Holden ; J. Wudel ; P K Pal ; R. De La Fuente-Fernandez ; D B Calne ; A J StoesslIn vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
000098 (2000) R. De La Fuente-Fernández [Canada] ; P K Pal ; F J Vingerhoets ; A. Kishore ; M. Schulzer ; E K Mak ; T J Ruth ; B J Snow ; D B Calne ; A J StoesslEvidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
000102 (2000) R. De La Fuente-Fernández [Canada] ; A. Kishore ; D B Calne ; T J Ruth ; A J StoesslNigrostriatal dopamine system and motor lateralization.
000150 (2001) R. De La Fuente-Fernández [Canada] ; J Q Lu ; V. Sossi ; S. Jivan ; M. Schulzer ; J E Holden ; C S Lee ; T J Ruth ; D B Calne ; A J StoesslBiochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
000175 (2001) R. De La Fuente-Fernández [Canada] ; T J Ruth ; V. Sossi ; M. Schulzer ; D B Calne ; A J StoesslExpectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
000190 (2001) R. De La Fuente-Fernández [Canada] ; A S Lim ; V. Sossi ; J E Holden ; D B Calne ; T J Ruth ; A J StoesslApomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
000268 (2002) S. Furtado [Canada] ; M. Farrer ; Y. Tsuboi ; M L Klimek ; R. De La Fuente-Fernández ; J. Hussey ; P. Lockhart ; D B Calne ; O. Suchowersky ; A J Stoessl ; Z K WszolekSCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.
000281 (2003) J. Carr [Canada] ; R. De La Fuente-Fernández ; M. Schulzer ; E. Mak ; S M Calne ; D B CalneFamilial and sporadic Parkinson's disease usually display the same clinical features.
000339 (1992) D B Calne [Canada]The nature of Parkinson's disease.
000351 (1992) R F Peppard [Canada] ; W R Martin ; G D Carr ; E. Grochowski ; M. Schulzer ; M. Guttman ; P L Mcgeer ; A G Phillips ; J K Tsui ; D B CalneCerebral glucose metabolism in Parkinson's disease with and without dementia.
000387 (1992) M. Schulzer [Canada] ; E. Mak ; D B CalneThe antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic.
000389 (1992) D B Calne [Canada]The free radical hypothesis in idiopathic parkinsonism: evidence against it.
000422 (1992) D B Calne [Canada] ; B J Snow ; C. LeeCriteria for diagnosing Parkinson's disease.
000491 (1992) M. Cordes [Canada] ; B J Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D B Calne[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "D B Calne" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "D B Calne" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    D B Calne
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022